Article Information
History
- May 9, 2024.
Article Versions
- Version 1 (March 4, 2024 - 18:06).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Kenneth C.Y. Wong1,
- Perry B.M. Leung8,
- Benedict K.W. Lee8,
- Pak C. Sham*,8,
- Simon S.Y. Lui*,8 and
- Hon-Cheong So*,1,2,3,4,5,6,7
- 1School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, China
- 2KIZ-CUHK Joint Laboratory of Bioresources and Molecular Research of Common Diseases, Kunming Institute of Zoology and The Chinese University of Hong Kong, Hong Kong, China
- 3Department of Psychiatry, The Chinese University of Hong Kong, Hong Kong, China
- 4CUHK Shenzhen Research Institute, Shenzhen, China
- 5Margaret K. L. Cheung Research Centre for Management of Parkinsonism, The Chinese University of Hong Kong, Hong Kong, China
- 6Brain and Mind Institute, The Chinese University of Hong Kong, Shatin, Hong Kong, China
- 7Hong Kong Branch of the Chinese Academy of Sciences Center for Excellence in Animal Evolution and Genetics, The Chinese University of Hong Kong, Shatin, Hong Kong, China
- 8Department of Psychiatry, The University of Hong Kong, Hong Kong, China
- ↵*Author to whom correspondence should be addressed. email: hcso{at}cuhk.edu.hk
Posted May 09, 2024.
Long-term Metabolic Side Effects of Second-Generation Antipsychotics in Chinese Patients with Schizophrenia: A Within-Subject Approach with modelling of dosage effects
